title: Differential expression of CD90 and CD14 stem cell markers in malignant breast cancer cell lines.
abstract: The recently emerged concept of cancer stem cell (CSC) has led to a new hypothesis on the basis for tumor progression. Basically, the CSC theory hypothesizes the presence of a hierarchically organized and relatively rare cell population, which is responsible for tumor initiation, self-renewal, and maintenance, in addition to accumulation of mutation and resistance to chemotherapy. CSCs have recently been described in breast cancer. Different genetic markers have been used to isolate breast CSCs, none of which have been correlated with the tumorigenicity or metastatic potential of the cells, limiting their precise characterization and clinical application in the development of therapeutic protocols. Here, we sought for subpopulations of CSCs by analyzing 10 judiciously chosen stem cell markers in a normal breast cell line (MCF10-A) and in four human breast cancer cell lines (MCF-7, MDA-MB-231, MDA-MB-435, and Hs578-T) displaying different degrees of metastatic and invasiveness potential. We were able to identify two markers, which are differentially expressed in nontumorigenic versus tumor cells. The CD90 marker was highly expressed in the malignant cell lines. Interestingly, the CD14 molecule displayed higher expression levels in the nontumorigenic cell line. Therefore, we demonstrated that these two markers, which are more commonly used to isolate and characterize stem cells, are differentially expressed in breast tumor cells, when compared with nontumorigenic breast cells.
authors.affiliation: Biochemistry Department, Chemistry Institute, Cell and Molecular Therapy Center (NUCEL), University of São Paulo, 05508-000 São Paulo, Brazil.
authors.forename: A R M
authors.initials: AR
authors.lastname: Lobba
authors.forename: M F
authors.initials: MF
authors.lastname: Forni
authors.forename: A C O
authors.initials: AC
authors.lastname: Carreira
authors.forename: M C
authors.initials: MC
authors.lastname: Sogayar
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis; D001943:Breast Neoplasms / Q000175:diagnosis / Q000235:genetics; D005260:Female; D005434:Flow Cytometry; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D018950:Lipopolysaccharide Receptors / Q000032:analysis* / Q000235:genetics; D061986:MCF-7 Cells; D009362:Neoplasm Metastasis; D014411:Neoplastic Stem Cells / Q000737:chemistry* / Q000473:pathology; D012333:RNA, Messenger / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D018800:Thy-1 Antigens / Q000032:analysis* / Q000235:genetics
chemical_list: D014408:Biomarkers, Tumor; D018950:Lipopolysaccharide Receptors; D012333:RNA, Messenger; D018800:Thy-1 Antigens